Narcolepsy Drugs Market Predicted to Achieve Striking 11.2% CAGR, Surging from US$3875.1 Million in 2021 to US$6588.0 Million by 2026
The global narcolepsy drugs market is poised for robust growth in the coming years, with the forecast period from 2021 to 2026 showing promising signs of substantial revenue expansion. Fairfield Market Research predicts an impressive Compound Annual Growth Rate (CAGR) of 11.2%, propelling the market value from US$3875.1 million in 2021 to an estimated US$6588.0 million by 2026. Narcolepsy, a neurological condition affecting approximately one in every 2000 individuals in the U.S., brings with it a slew of challenges, including
Read more